Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Arnon

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|August 12, 2023
Amyloid Precursor Protein and Tau Peptides Linked Together Ameliorate Loss of Cognition in an Alzheimer's Disease Animal ModelRuth Maron, Yaron Vinik, Michael Tsoory, et al.
Immunology Letters|August 28, 2007
The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cellsRina Aharoni, Hagar Sonego, Ori Brenner, et al.
International Journal of Molecular Sciences|May 9, 2020
Peptide Interference with APP and Tau Association: Relevance to Alzheimer's Disease AmeliorationRuth Maron, Gad Armony, Michael Tsoory, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2005
The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis miceRina Aharoni, Raya Eilam, Hagit Domev, et al.
Journal of Neuroimmunology|September 22, 2009
Transplanted myogenic progenitor cells express neuronal markers in the CNS and ameliorate disease in experimental autoimmune encephalomyelitisRina Aharoni, Elizabeta Aizman, Ora Fuchs, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 21, 2006
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel diseaseRina Aharoni, Basak Kayhan, Ori Brenner, et al.
Journal of Neuroimmunology|July 4, 2012
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitisRina Aharoni, Ravit Saada, Raya Eilam, et al.
Glia|February 10, 2018
Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosisRaya Eilam, Menahem Segal, Rafael Malach, et al.
Molecular Immunology|September 11, 2002
A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunizationTamar Ben-Yedidia, Anne-Sophie Beignon, Charalambos D Partidos, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 2011
Beneficial effect of glatiramer acetate treatment on syndecan-1 expression in dextran sodium sulfate colitisDoron Yablecovitch, Maytal Shabat-Simon, Rina Aharoni, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|August 12, 2023
Amyloid Precursor Protein and Tau Peptides Linked Together Ameliorate Loss of Cognition in an Alzheimer's Disease Animal ModelRuth Maron, Yaron Vinik, Michael Tsoory, et al.
Immunology Letters|August 28, 2007
The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cellsRina Aharoni, Hagar Sonego, Ori Brenner, et al.
International Journal of Molecular Sciences|May 9, 2020
Peptide Interference with APP and Tau Association: Relevance to Alzheimer's Disease AmeliorationRuth Maron, Gad Armony, Michael Tsoory, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2005
The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis miceRina Aharoni, Raya Eilam, Hagit Domev, et al.
Journal of Neuroimmunology|September 22, 2009
Transplanted myogenic progenitor cells express neuronal markers in the CNS and ameliorate disease in experimental autoimmune encephalomyelitisRina Aharoni, Elizabeta Aizman, Ora Fuchs, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 21, 2006
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel diseaseRina Aharoni, Basak Kayhan, Ori Brenner, et al.
Journal of Neuroimmunology|July 4, 2012
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitisRina Aharoni, Ravit Saada, Raya Eilam, et al.
Glia|February 10, 2018
Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosisRaya Eilam, Menahem Segal, Rafael Malach, et al.
Molecular Immunology|September 11, 2002
A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunizationTamar Ben-Yedidia, Anne-Sophie Beignon, Charalambos D Partidos, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 2011
Beneficial effect of glatiramer acetate treatment on syndecan-1 expression in dextran sodium sulfate colitisDoron Yablecovitch, Maytal Shabat-Simon, Rina Aharoni, et al.
Pageof 6